They did not comment on it, but should have noticed they tell a pretty accurate tail and timeline for some very odd FDA timing of decisions. Also my request was pre-Woodcock back and forth communications, now the story might be considerably different. As a note most if not all of my FDA/ICER communications have been forwarded to Amarin. Amarin has almost never initiated an email to me. I have had an Amarin call with JT. I have had joint emails that led to calls with other investors and either JT or Kennedy.
My posts are to keep a public record of my opinion and the FDA’s actions.
Market Data 
Markets 
AI
